2019
DOI: 10.22159/ijap.2020v12i1.35312
|View full text |Cite
|
Sign up to set email alerts
|

SOLID LIPID NANOPARTICLES (SLNs) AS NANO DRUG DELIVERY CARRIERS: PREPARATION, CHARACTERIZATION AND APPLICATION

Abstract: Over the last few years, there has been a significant consideration of solid lipid nanoparticles (SLNs) as an alternative method to other colloidal dispersion methods for drug delivery. Special consideration has been given to the use of SLNs as a drug carrier in recent years. SLNs are aqueous dispersions in which the colloidal particles consist of solid lipids that are biodegradable. As a result of their physical stability, the protection of the entrapped drug from decomposition, the provision of controlled dr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 41 publications
0
20
0
Order By: Relevance
“…There was a statistically significant difference between pre-and posttest data of depression in the control group, but the control group has not received any education. Nowadays, social media users are increased worldwide [11,12]. Suddenly, in Tamil Nadu, social media users increased.…”
Section: Discussionmentioning
confidence: 99%
“…There was a statistically significant difference between pre-and posttest data of depression in the control group, but the control group has not received any education. Nowadays, social media users are increased worldwide [11,12]. Suddenly, in Tamil Nadu, social media users increased.…”
Section: Discussionmentioning
confidence: 99%
“…The amount of the non-capsulated drug in the supernatant was estimated spectrophotometrically at 269 nm, utilizing an ultraviolet spectrophotometer (Shimadzu, Yokohama, Japan). Different characterizations such as zeta potential (ZP), particle size as well as the polydispersity index (PDI) of the formulated nanoparticles were measured using a Zetasizer (Malvern Instruments Ltd., Malvern, UK) [ 40 , 41 ], while morphology of the surface of the nanoparticles was confirmed using transmission electron microscopy (TEM) (model JTEM-2100, Tokyo, Japan) [ 42 ]. Release of the drug from different trials was carried out using dialysis bag method [ 43 ] at simulated gastric fluid containing 0.1 N HCl and final pH equalsing 1.2 for 2 h and then substituted with phosphate buffer (pH = 6.8) for the next 10 h. Temperature was kept at 37 ± 1 °C, and drug was assayed spectrophotometrically at 269 nm (UV-visible spectrophotometer, Shimadzu, Yokohama, Japan) [ 44 ].…”
Section: Methodsmentioning
confidence: 99%
“…The particle size, zeta potential (ZP), and polydispersity index (PDI) of all prepared DOXY-PNPs were measured using a zeta seizer (Malvern Instruments Ltd., Malvern, UK) [ 69 ]. Each sample of DOXY-PNPs was diluted with distilled water before analysis [ 70 , 71 ].…”
Section: Methodsmentioning
confidence: 99%